Cargando…
Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways
INTRODUCTION: The aim of our research was to investigate changes in the molecular background of the immune response in the chronic phase (CP) of chronic myeloid leukaemia (CML) during treatment with tyrosine kinase inhibitors (TKIs). METHODS: Global gene and miRNA expression profiles were assessed u...
Autores principales: | Janowski, Michał, Ulańczyk, Zofia, Łuczkowska, Karolina, Sobuś, Anna, Rogińska, Dorota, Pius-Sadowska, Ewa, Gniot, Michał, Kozłowski, Krzysztof, Lewandowski, Krzysztof, Helbig, Grzegorz, Machaliński, Bogusław, Paczkowska, Edyta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553433/ https://www.ncbi.nlm.nih.gov/pubmed/36238136 http://dx.doi.org/10.2147/OTT.S371847 |
Ejemplares similares
-
Molecular Mechanisms of Bortezomib Action: Novel Evidence for the miRNA–mRNA Interaction Involvement
por: Łuczkowska, Karolina, et al.
Publicado: (2020) -
Effect of Bortezomib on Global Gene Expression in PC12-Derived Nerve Cells
por: Łuczkowska, Karolina, et al.
Publicado: (2020) -
Novel design of (PEG-ylated)PAMAM-based nanoparticles for sustained delivery of BDNF to neurotoxin-injured differentiated neuroblastoma cells
por: Dąbkowska, Maria, et al.
Publicado: (2020) -
Apoptosis Evaluation in Circulating CD34+-Enriched Hematopoietic Stem and Progenitor Cells in Patients with Abnormally Increased Production of Endogenous Glucocorticoids in Course of Cushing’s Syndrome
por: Kawa, Miłosz P., et al.
Publicado: (2022) -
CXCL8, CCL2, and CMV Seropositivity as New Prognostic Factors for a Severe COVID-19 Course
por: Pius-Sadowska, Ewa, et al.
Publicado: (2022)